THMO (ThermoGenesis Holdings) EBIT per Share: $-2.66 (TTM As of Mar. 2024)

What is ThermoGenesis Holdings EBIT per Share?

ThermoGenesis Holdings THMO 16 EBIT per Share is $-2.66 as of Mar. 2024. GuruFocus rates THMO with a GF Score™ of 16/100.

ThermoGenesis Holdings's EBIT per Share for the three months ended in Mar. 2024 was $-0.14. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.66.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for ThermoGenesis Holdings's EBIT per Share or its related term are showing as below:

THMO's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 9.5
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

ThermoGenesis Holdings's EBIT for the three months ended in Mar. 2024 was $-0.55 Mil.

ThermoGenesis Holdings (OTCPK:THMO) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

ThermoGenesis Holdings EBIT per Share Related Terms

ThermoGenesis Holdings EBIT per Share Historical Data

* Premium members only.

The historical data trend for ThermoGenesis Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ThermoGenesis Holdings EBIT per Share Chart

ThermoGenesis Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-89.21

-63.59

-22.05

-11.25

-3.75

ThermoGenesis Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															-1.02	-0.70	-0.65	-1.18	-0.14

16GF Score

ThermoGenesis Holdings Inc THMO

EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

ThermoGenesis Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

ThermoGenesis Holdings's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-8.887	/	2.368
=	-3.75

ThermoGenesis Holdings's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.549	/	4.026
=	-0.14

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.66

Frequently Asked Questions Learn more about EBIT per Share →

What does a EBIT per Share of $-2.66 mean?

ThermoGenesis Holdings (THMO) has a EBIT per Share of $-2.66 as of Mar. 2024. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on ThermoGenesis Holdings and its competitors.

Is ThermoGenesis Holdings' EBIT per Share too high?

ThermoGenesis Holdings' current EBIT per Share is $-2.66. Overall, ThermoGenesis Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.

How does ThermoGenesis Holdings' EBIT per Share compare to MSIU and MOTS?

ThermoGenesis Holdings' EBIT per Share of $-2.66 can be compared against companies in the Medical Devices & Instruments industry. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT per Share for a Medical Devices & Instruments company?

The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT per Share mean?

A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on ThermoGenesis Holdings and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ThermoGenesis Holdings's current EBIT per Share is $-2.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is ThermoGenesis Holdings stock overvalued right now?

ThermoGenesis Holdings (THMO) has a current EBIT per Share of $-2.66. The current EBIT per Share is $-2.66. ThermoGenesis Holdings' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT per Share calculated?

EBIT per Share is calculated from a company's financial statements. For ThermoGenesis Holdings (THMO), the current EBIT per Share is $-2.66 as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ThermoGenesis Holdings Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies MSIU MOTS ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE ZBH PODD XSWX:SOON SHSE:688271 TSE:7733 TSE:6869 LSE:SN.PEN

Address 2711 Citrus Road, Rancho Cordova, CA, USA, 95742

Website https://www.thermogenesis.com

ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.

16GF Score

Get the complete analysis for THMO

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View THMO Analysis

See EBIT per Share data for all stocks →